Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00483405
What this trial is testing

Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer

Who this might be right for
Liver Cancer
UNC Lineberger Comprehensive Cancer Center 33
Not applicableActive Not RecruitingNCT04390724
What this trial is testing

Optimizing Y90 Therapy for Radiation Lobectomy

Who this might be right for
HCCResectionTransplant+2 more
Northwestern University 104
Not applicableStudy completedNCT01043523
What this trial is testing

Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

Who this might be right for
Liver NeoplasmsAdenomaCarcinoma+1 more
Bayer 52
Early research (Phase 1)Study completedNCT00475956
What this trial is testing

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

Who this might be right for
Neoplasms
AstraZeneca 40
Large-scale testing (Phase 3)UnknownNCT03469479
What this trial is testing

Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 252
Not applicableLooking for participantsNCT06690970
What this trial is testing

Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients

Who this might be right for
PSMA-related DiseaseProstate CancerPositron Emission Tomography+3 more
Tianjin Medical University 500
Large-scale testing (Phase 3)Study completedNCT00003994
What this trial is testing

Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer

Who this might be right for
Childhood HepatoblastomaRecurrent Childhood Liver CancerStage I Childhood Liver Cancer
Children's Oncology Group 277
Not applicableUnknownNCT01281683
What this trial is testing

Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 60
Early research (Phase 1)Looking for participantsNCT07369505
What this trial is testing

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Who this might be right for
Breast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more
SAPU NANO (US) LLC 27
Testing effectiveness (Phase 2)Study completedNCT00321594
What this trial is testing

Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 54
Large-scale testing (Phase 3)Looking for participantsNCT06185556
What this trial is testing

COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases

Who this might be right for
Colorectal CancerLiver MetastasesLiver Metastasis Colon Cancer+1 more
Amsterdam UMC, location VUmc 78
Testing effectiveness (Phase 2)Study completedNCT03698461
What this trial is testing

Treatment of Colorectal Liver Metastases With Immunotherapy and Bevacizumab

Who this might be right for
Colorectal NeoplasmsNeoplasm MetastasisColonic Neoplasms+1 more
Asan Medical Center 20
Early research (Phase 1)Looking for participantsNCT05488522
What this trial is testing

SBRT With Atezo/Bev for HCC

Who this might be right for
Hepatocellular Carcinoma
Abramson Cancer Center at Penn Medicine 18
Not applicableEnded earlyNCT05184283
What this trial is testing

Utilization of MAsS in Patients Undergoing LT for HCC

Who this might be right for
NAFLDHepatocellular CarcinomaLiver Diseases+3 more
Columbia University 11
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Ended earlyNCT02102022
What this trial is testing

Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma

Who this might be right for
Advanced Gastrointestinal (GI) MalignanciesHepatocellular CarcinomaGastric Cancer+1 more
Polaris Group 140
Not applicableStudy completedNCT00857805
What this trial is testing

Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Loma Linda University 76
Early research (Phase 1)Study completedNCT02416466
What this trial is testing

CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases

Who this might be right for
Liver Metastases
Roger Williams Medical Center 8
Testing effectiveness (Phase 2)Looking for participantsNCT07219459
What this trial is testing

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

Who this might be right for
Unresectable or Metastatic Hepatocellular CarcinomaChild-Pugh A Hepatocellular CarcinomaFailure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound
CatalYm GmbH 104
Early research (Phase 1)Ended earlyNCT03144661
What this trial is testing

An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies

Who this might be right for
Hepatocellular Carcinoma (HCC)CholangiocarcinomaEsophageal Cancer+3 more
Incyte Corporation 25
Next Page